Cover
Cover - shares | 6 Months Ended | |
Jun. 30, 2024 | Jul. 30, 2024 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity Interactive Data Current | No | |
Amendment Flag | false | |
Document Period End Date | Jun. 30, 2024 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q2 | |
Entity Information [Line Items] | ||
Entity Registrant Name | HI-GREAT GROUP HOLDING COMPANY | |
Entity Central Index Key | 0001807616 | |
Entity File Number | 000-56200 | |
Entity Tax Identification Number | 46-2218131 | |
Entity Incorporation, State or Country Code | NV | |
Current Fiscal Year End Date | --12-31 | |
Entity Current Reporting Status | Yes | |
Entity Shell Company | false | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Incorporation, Date of Incorporation | Sep. 30, 2010 | |
Entity Contact Personnel [Line Items] | ||
Entity Address, Address Line One | 621 South Virgil Avenue | |
Entity Address, Address Line Two | #470 | |
Entity Address, City or Town | Los Angeles | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 90005 | |
Entity Phone Fax Numbers [Line Items] | ||
City Area Code | (213) | |
Local Phone Number | 219-7746 | |
Entity Listings [Line Items] | ||
Title of 12(b) Security | None | |
No Trading Symbol Flag | true | |
Security Exchange Name | NONE | |
Entity Common Stock, Shares Outstanding | 100,000,000 |
Balance Sheets
Balance Sheets - USD ($) | Jun. 30, 2024 | Dec. 31, 2023 |
Current assets: | ||
Cash | $ 116 | $ 733 |
Inventory | 47,400 | 54,090 |
Advances to Suppliers | 1,750 | 1,750 |
Receivable from Citi Bank | ||
Total current assets | 49,266 | 56,573 |
Non-current assets: | ||
Total assets | 63,049 | 84,138 |
Current liabilities: | ||
Accounts payable | 37,400 | 27,400 |
Deferred revenue | ||
State Income Tax Payable | ||
Total current liabilities | 188,402 | 193,551 |
Non-Current Liabilities: | ||
Total Liabilities | 195,771 | 193,551 |
Commitments and Contingencies | ||
Stockholders’ Deficit: | ||
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued and outstanding | ||
Common stock, par value $0.001 per share; 1,100,000,000 shares authorized; 100,000,000 shares issued and outstanding as of December 30, 2022 and December 31, 2021, respectively | 100,000 | 100,000 |
Additional paid in capital | 629,566 | 629,566 |
Accumulated Deficit | (862,289) | (838,979) |
Total stockholders’ equity | (132,723) | (109,413) |
Total liabilities and stockholders’ equity | 63,049 | 84,138 |
Related Party | ||
Non-current assets: | ||
Right of use asset – operating lease – related party | 13,783 | 27,565 |
Current liabilities: | ||
Accounts payable – related party | ||
Notes payable – related party | ||
Loan payable – related party | ||
Accrued royalty– related party | 151,002 | 144,920 |
Operating lease obligation, current portion – related party | 21,231 | |
Non-Current Liabilities: | ||
Operating lease obligation – related party | $ 7,369 |
Balance Sheets (Parentheticals)
Balance Sheets (Parentheticals) - $ / shares | Jun. 30, 2024 | Dec. 31, 2023 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in Dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, shares issued | ||
Preferred stock, shares outstanding | ||
Common stock, par value (in Dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 1,100,000,000 | 1,100,000,000 |
Common stock, shares issued | 100,000,000 | 100,000,000 |
Common stock, shares outstanding | 100,000,000 | 100,000,000 |
Profit and Loss (Unaudited)
Profit and Loss (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Income Statement [Abstract] | ||||
Sales | $ 15,280 | $ 44,562 | $ 24,330 | $ 61,831 |
Cost of sales-royalty– related party | (3,820) | (11,139) | (6,083) | (15,456) |
Cost of goods sales | (4,080) | (13,740) | (6,690) | (20,820) |
Gross profit | 7,380 | 19,683 | 11,558 | 25,555 |
Operating expenses: | ||||
Professional fees | 8,000 | 65,125 | 14,500 | 71,201 |
Depreciation Expense | 6,891 | 13,782 | ||
Rent expense | 7,500 | 15,000 | ||
General and administrative expenses | 3,852 | 5,658 | 5,448 | 5,913 |
Total operating expense | 18,743 | 78,283 | 33,730 | 92,114 |
Income (Loss) from operations | (11,363) | (58,600) | (22,172) | (66,559) |
Other income (expense): | ||||
Interest income | ||||
Interest expense | (569) | (1,138) | ||
Total other (expense) income | (569) | (1,138) | ||
Net income (loss) | $ (11,932) | $ (58,600) | $ (23,310) | $ (66,559) |
Net income (loss) per common share – basic (in Dollars per share) | ||||
Weighted average common shares (in Shares) | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 |
Profit and Loss (Unaudited) (Pa
Profit and Loss (Unaudited) (Parentheticals) - $ / shares | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Income Statement [Abstract] | ||||
Net income (loss) per common share – diluted |
Statements of Stockholders_ Def
Statements of Stockholders’ Deficit - USD ($) | Common Stock | Additional Paid-in Capital | Accumulated Deficit | Total |
Balance at Dec. 31, 2019 | $ 100,000 | $ 619,566 | $ (719,802) | $ (236) |
Balance (in Shares) at Dec. 31, 2019 | 100,000,000 | |||
Net income (loss) | (12,782) | (12,782) | ||
Balance at Dec. 31, 2020 | $ 100,000 | 619,566 | (732,584) | (13,018) |
Balance (in Shares) at Dec. 31, 2020 | 100,000,000 | |||
Net income (loss) | 2,579 | 2,579 | ||
Balance at Dec. 31, 2021 | $ 100,000 | 629,566 | (724,716) | 4,850 |
Balance (in Shares) at Dec. 31, 2021 | 100,000,000 | |||
Adjustment – Issuance of Stocks | 10,000 | 10,000 | ||
Adjustment | 5,289 | 5,289 | ||
Net income (loss) | 3,300 | 3,300 | ||
Balance at Dec. 31, 2022 | $ 100,000 | 629,566 | (723,396) | 6,170 |
Balance (in Shares) at Dec. 31, 2022 | 100,000,000 | |||
Adjustment | (1,980) | (1,980) | ||
Net income (loss) | (7,959) | (7,959) | ||
Balance at Mar. 31, 2023 | $ 100,000 | 629,566 | (731,355) | (1,789) |
Balance (in Shares) at Mar. 31, 2023 | 100,000,000 | |||
Balance at Dec. 31, 2022 | $ 100,000 | 629,566 | (723,396) | 6,170 |
Balance (in Shares) at Dec. 31, 2022 | 100,000,000 | |||
Net income (loss) | (66,559) | |||
Balance at Jun. 30, 2023 | $ 100,000 | 629,566 | (789,955) | (60,389) |
Balance (in Shares) at Jun. 30, 2023 | 100,000,000 | |||
Balance at Mar. 31, 2023 | $ 100,000 | 629,566 | (731,355) | (1,789) |
Balance (in Shares) at Mar. 31, 2023 | 100,000,000 | |||
Net income (loss) | (58,600) | (58,600) | ||
Balance at Jun. 30, 2023 | $ 100,000 | 629,566 | (789,955) | (60,389) |
Balance (in Shares) at Jun. 30, 2023 | 100,000,000 | |||
Net income (loss) | (24,838) | (24,838) | ||
Balance at Sep. 30, 2023 | $ 100,000 | 629,566 | (814,793) | (85,227) |
Balance (in Shares) at Sep. 30, 2023 | 100,000,000 | |||
Net income (loss) | (30,361) | (30,361) | ||
Balance at Dec. 31, 2023 | $ 100,000 | 629,566 | (838,979) | (109,413) |
Balance (in Shares) at Dec. 31, 2023 | 100,000,000 | |||
Adjustment | 6,175 | 6,175 | ||
Net income (loss) | (23,310) | (23,310) | ||
Balance at Jun. 30, 2024 | $ 100,000 | $ 629,566 | $ (862,289) | $ (132,723) |
Balance (in Shares) at Jun. 30, 2024 | 100,000,000 |
Statements of Cash Flows (Unaud
Statements of Cash Flows (Unaudited) - USD ($) | 6 Months Ended | |
Jun. 30, 2024 | Jun. 30, 2023 | |
Cash Flows from operating activities: | ||
Net Income | $ (23,310) | $ (70,718) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
Amortization of right of use asset – operating lease | ||
Changes in operating assets and liabilities: | ||
Inventory | 6,690 | 20,820 |
Advances to Suppliers | 7,500 | |
Receivable from CitiBank | ||
Accounts payable – related party | 10,000 | 11,500 |
Accrued royalty | 6,083 | 15,456 |
Accrued interest | ||
Loan Payable | ||
State Income Tax Payable | ||
Operating Lease Obligation (Current Portion) | 12,250 | |
Net cash provided (used) by operating activities | (538) | (3,192) |
Cash Flows from Investing Activities: | ||
Notes receivable – Related Party | ||
Right of Use Asset – Related Party | 13,782 | |
Net cash provided (used) by investing activities | 13,782 | |
Cash Flows from Financing Activities: | ||
Proceeds from common stock – related party | ||
Right of Use Liabilities | (21,231) | |
Operating Lease Obligation | 7,369 | (12,250) |
Retained Earnings | ||
Net cash provided (used) by financing activities | (13,862) | (12,250) |
Effect of exchange rate changes | ||
Net change in cash | (618) | (15,442) |
Cash at beginning of period | 733 | 30,577 |
Cash at end of period | 116 | 15,136 |
Non-cash investing and financing activities: | ||
Note receivable-related party | ||
Common stock-related party | ||
Right of use asset – operating lease | $ 0 |
Organization and Description of
Organization and Description of Business | 6 Months Ended |
Jun. 30, 2024 | |
Organization and Description of Business [Abstract] | |
ORGANIZATION AND DESCRIPTION OF BUSINESS | NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS Basis of Presentation and Organization Hi-Great Group Holding Company (the “Company”) is a development stage enterprise that was originally incorporated, on September 30, 2010, under the laws of the State of Nevada. On March 8, 2019, the eight judicial District Court of Nevada appointed Custodian Ventures, LLC as custodian for Hi-Great Group Holding Company, proper notice having been given to the officers and directors of Hi-Great Group Holding Company. There was no opposition. On March 15, 2019, the Company filed a certificate of revival with the state of Nevada, appointing David Lazar as President, Secretary, Treasurer and Director. On October 11, 2019, Custodian Ventures entered into a stock purchase agreement whereby they transferred 70,000,000 shares of common stock to Esther Yang in exchange for $225,000 in cash. As a result of the sale, there was a change of control of the Company. There is no family relationship or other relationship between the Seller and the Purchaser. On March 19, 2020, the Company entered in a licensing agreement with SellaCare, Inc. for the licensing of Patents and all future products developed by the SellaCare, Inc. The licensing agreement calls for the Company to pay 25% of all Gross revenues or $1,000, whichever is greater and not less than $1,000, beginning April 30, 2020 and payable the 15 th On March 16, 2020, the Company entered into a land lease for property located in the unincorporated area of Pearblossom, County of Los Angeles, California, in agreement with Sella Property, LLC. Sella Property, LLC is an entity controlled by Esther Yang. The lease calls for rent payments of $30,000 in annual installments due on the 16 th In March 2020, the World Health Organization categorized the novel coronavirus (COVID-19) as a pandemic, and it continues to spread throughout the United States and the rest of the world with different geographical locations impacted more than others. The outbreak of COVID-19 and public and private sector measures to reduce its transmission, such as the imposition of social distancing and orders to work-from-home, stay-at-home and shelter-in-place, have had a minimal impact on our day to day operations. However, this could impact our efforts to enter into a business combination as other businesses have had to adjust, reduce or suspend their operating activities. The extent of the impact will vary depending on the duration and severity of the economic and operational impacts of COVID-19. The Company is unable to predict the ultimate impact at this time. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 6 Months Ended |
Jun. 30, 2024 | |
Summary of Significant Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying unaudited financial statements are prepared on the basis of accounting principles generally accepted in the United States of America (“GAAP”). The accompanying unaudited financial statements reflect all adjustments, consisting of only normal recurring items, which, in the opinion of management, are necessary for a fair statement of the results of operations for the periods shown and are not necessarily indicative of the results to be expected for the six months ending June 30, 2024. The Company is a development stage enterprise devoting substantial efforts to establishing a new business, financial planning, raising capital, and research into products which may become part of the Company’s product portfolio. The Company has not realized significant sales through since inception. A development stage company is defined as one in which all efforts are devoted substantially to establishing a new business and, even if planned principal operations have commenced, revenues are insignificant. Use of estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates Cash and Cash Equivalents For purposes of reporting within the statements of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of six months or less to be cash and cash equivalents. Reclassifications No reclassifications have been made to the current period financial information to conform to the presentation used in the financial statements for the six months ending June 30, 2024. Revenue Recognition The Company records revenue in accordance with FASB Accounting Standards Codification (“ASC”) as topic 606 (“ASC 606”). The revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the Company’s revenue recognition policies and significant judgments employed in the determination of revenue. The Company is involved in Agritourism and sells herbal supplements. The Company sells herbal supplements it buys directly from SellaCare, Inc. and sells those supplements using the SellaCare brand. SellaCare, Inc is a company that is controlled by the Company’s majority shareholder. Cost of Goods Sold Cost of sales includes all direct expenses incurred to produce the revenue for the period. This includes, but is not limited to, product cost and shipping. Cost of goods sold are recorded in the same period as the resulting revenue. The company pays a sales based royalty payment of 25% of gross revenue to SellaCare, Inc., its related party. This royalty expense is included in cost of goods sold. Leases The Company adopted the new lease accounting standard, “Accounting Standards Codification Topic 842 Leases (ASC 842)” using the modified retrospective basis for all agreements existing as of January 1, 2019 as described further below under Accounting Standards Adopted The Company recognizes a right-of-use asset and lease liability for all financing and operating leases with terms greater than twelve months. The lease liability is measured based on the present value of the lease payments not yet paid. The right-of-use asset is measured based on the initial measurement of the lease liability adjusted for any direct costs incurred upon commencement of the lease. The right-of-use assets are amortized on a straight-line basis over the lease term, and are tested for impairment in a manner consistent with the other long-lived assets held by the Company. Adoption of Recent Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations. |
Going Concern
Going Concern | 6 Months Ended |
Jun. 30, 2024 | |
Going Concern [Abstract] | |
GOING CONCERN | NOTE 3 – GOING CONCERN The accompanying financial statements have been prepared assuming the continuation of the Company as a going concern. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and is dependent on debt and equity financing to fund its operations. Management of the Company is making efforts to raise additional funding until a registration statement relating to an equity funding facility is in effect. While management of the Company believes that it will be successful in its capital formation and planned operating activities, there can be no assurance that the Company will be able to raise additional equity capital or be successful in the development and commercialization of the products it develops or initiates collaboration agreements thereon. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern. |
Related Party Transactions
Related Party Transactions | 6 Months Ended |
Jun. 30, 2024 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 4 – RELATED PARTY TRANSACTIONS On December 27, 2019, the company obtained a loan in the amount of $5,000 from Jung Ho Yang. The note bears an interest rate of 5% and matures on November 30, 2020. As of December 31, 2020, there is $253 of interest accrued on this note. This note is paid. On January 28, 2020, the company obtained a loan in the amount of $10,000 from Sellacare America, Inc. The note bears an interest rate of 5% and matures on November 30, 2020 As of December 31, 2020, there is $463 of interest accrued on this note. This note is paid. On March 19, 2020, the Company entered in a licensing agreement with SellaCare, Inc. for the licensing of Patents and all future products developed by the SellaCare, Inc. The licensing agreement calls for the Company to pay 25% of all Gross revenues or $1,000, whichever is greater and not less than $1,000, beginning April 30, 2020 and payable the 15 th On March 16, 2020, the Company entered into a land lease for property located in the unincorporated area in Pearblossom, County of Los Angeles, California, in agreement with Sella Property, LLC. Sella Property, LLC is an entity controlled by Company’s majority shareholder. The lease calls for rent payments of $30,000 in annual installments due on the 16th day of March each year. The lease begins March 16, 2020, and matures March 16, 2025. As of June 30, 2024, a total of $0 |
Operating Lease
Operating Lease | 6 Months Ended |
Jun. 30, 2024 | |
Operating Lease [Abstract] | |
OPERATING LEASE | NOTE 5 – OPERATING LEASE On February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842). The ASU introduces a new leasing model for both lessees and lessors. Topic 842 provides guidance in how to identify whether a lease arrangement exists. Management has evaluated its leasing arrangement and has classified it as operating lease. Operating Lease Obligations On March 16, 2020, the Company entered into a land lease for property located in the unincorporated area Pearblossom, County of Los Angeles, State of California.in agreement with Sella Property, LLC. Sella Property, LLC is a company controlled by the majority shareholder of the Company. The lease calls for rent payments of $30,000 in annual installments due on the 16th day of March each year. The lease begins March 16, 2020 and matures March 16, 2025. Lease obligations at June 30, 2024 consisted of the following: Right to Use Right to Use Liability – USD 7,369 The following Cost related to the lease of the Company for the year ended June 30, 2024 Lease Depreciation -USD 6,891 Lease Interest -USD 569 Total Lease Cost -USD 7,460 |
Subsequent Events
Subsequent Events | 6 Months Ended |
Jun. 30, 2024 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 6 – SUBSEQUENT EVENTS Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855, from the balance sheet date through the date the financial statements were issued and has determined that no material subsequent events exist. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||
Jun. 30, 2024 | Dec. 31, 2023 | Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Pay vs Performance Disclosure | ||||||||||
Net Income (Loss) | $ (11,932) | $ (30,361) | $ (24,838) | $ (58,600) | $ (7,959) | $ (23,310) | $ (66,559) | $ 3,300 | $ 2,579 | $ (12,782) |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Jun. 30, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 6 Months Ended |
Jun. 30, 2024 | |
Summary of Significant Accounting Policies [Abstract] | |
Basis of presentation | Basis of presentation The accompanying unaudited financial statements are prepared on the basis of accounting principles generally accepted in the United States of America (“GAAP”). The accompanying unaudited financial statements reflect all adjustments, consisting of only normal recurring items, which, in the opinion of management, are necessary for a fair statement of the results of operations for the periods shown and are not necessarily indicative of the results to be expected for the six months ending June 30, 2024. The Company is a development stage enterprise devoting substantial efforts to establishing a new business, financial planning, raising capital, and research into products which may become part of the Company’s product portfolio. The Company has not realized significant sales through since inception. A development stage company is defined as one in which all efforts are devoted substantially to establishing a new business and, even if planned principal operations have commenced, revenues are insignificant. |
Use of estimates | Use of estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates |
Cash and Cash Equivalents | Cash and Cash Equivalents For purposes of reporting within the statements of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of six months or less to be cash and cash equivalents. |
Reclassifications | Reclassifications No reclassifications have been made to the current period financial information to conform to the presentation used in the financial statements for the six months ending June 30, 2024. |
Revenue Recognition | Revenue Recognition The Company records revenue in accordance with FASB Accounting Standards Codification (“ASC”) as topic 606 (“ASC 606”). The revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the Company’s revenue recognition policies and significant judgments employed in the determination of revenue. The Company is involved in Agritourism and sells herbal supplements. The Company sells herbal supplements it buys directly from SellaCare, Inc. and sells those supplements using the SellaCare brand. SellaCare, Inc is a company that is controlled by the Company’s majority shareholder. |
Cost of Goods Sold | Cost of Goods Sold Cost of sales includes all direct expenses incurred to produce the revenue for the period. This includes, but is not limited to, product cost and shipping. Cost of goods sold are recorded in the same period as the resulting revenue. The company pays a sales based royalty payment of 25% of gross revenue to SellaCare, Inc., its related party. This royalty expense is included in cost of goods sold. |
Leases | Leases The Company adopted the new lease accounting standard, “Accounting Standards Codification Topic 842 Leases (ASC 842)” using the modified retrospective basis for all agreements existing as of January 1, 2019 as described further below under Accounting Standards Adopted The Company recognizes a right-of-use asset and lease liability for all financing and operating leases with terms greater than twelve months. The lease liability is measured based on the present value of the lease payments not yet paid. The right-of-use asset is measured based on the initial measurement of the lease liability adjusted for any direct costs incurred upon commencement of the lease. The right-of-use assets are amortized on a straight-line basis over the lease term, and are tested for impairment in a manner consistent with the other long-lived assets held by the Company. |
Adoption of Recent Accounting Pronouncements | Adoption of Recent Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations. |
Organization and Description _2
Organization and Description of Business (Details) - USD ($) | 6 Months Ended | ||||
Mar. 16, 2020 | Oct. 11, 2019 | Jun. 30, 2024 | Apr. 30, 2020 | Mar. 19, 2020 | |
Organization and Description of Business [Line Items] | |||||
Date of Incorporation | Sep. 30, 2010 | ||||
Common stock shares (in Shares) | 70,000,000 | ||||
Stock exchange in cash | $ 225,000 | ||||
Licensing agreement | 25% | ||||
Gross revenues | $ 1,000 | $ 1,000 | |||
Payments for rent | $ 30,000 |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Details) | 6 Months Ended |
Jun. 30, 2024 | |
Summary of Significant Accounting Policies [Abstract] | |
Royalty payment, percentage | 25% |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) | 6 Months Ended | |||||||
Jan. 28, 2020 | Dec. 27, 2019 | Jun. 30, 2024 | Dec. 31, 2023 | Dec. 31, 2020 | Apr. 30, 2020 | Mar. 19, 2020 | Mar. 16, 2020 | |
Related Party Transaction [Line Items] | ||||||||
Licensing agreement | 25% | |||||||
Gross revenues | $ 1,000 | $ 1,000 | ||||||
Licensing expense | $ 53,365 | |||||||
Rent payments | $ 30,000 | |||||||
Related Party [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Loan payable to related party | ||||||||
Jung Ho Yang [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
loan amount | $ 5,000 | |||||||
Interest accrued | $ 253 | |||||||
Sellacare America, Inc [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
loan amount | $ 10,000 | |||||||
Interest accrued | $ 463 | |||||||
Sella Property, LLC [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Lease description | The lease begins March 16, 2020, and matures March 16, 2025. | |||||||
Loan [Member] | Jung Ho Yang [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Interest rate percentage | 5% | |||||||
Maturity date | Nov. 30, 2020 | |||||||
Loan [Member] | Sellacare America, Inc [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Interest rate percentage | 5% | |||||||
Maturity date | Nov. 30, 2020 |
Operating Lease (Details)
Operating Lease (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||||
Mar. 16, 2020 | Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | |
Operating Lease [Line Items] | ||||||
Rent payments | $ 30,000 | |||||
Lease depreciation | $ 6,891 | $ 13,782 | ||||
Lease interest | 569 | 1,138 | ||||
Lease cost | 7,460 | |||||
Related Party [Member] | ||||||
Operating Lease [Line Items] | ||||||
Right to use asset | 13,783 | 13,783 | $ 27,565 | |||
Right to use liability | $ 7,369 | $ 7,369 | ||||
Sella Property, LLC [Member] | ||||||
Operating Lease [Line Items] | ||||||
Lease term description | The lease begins March 16, 2020 and matures March 16, 2025. |